Combined Measurement of Soluble ST2 and Amino-Terminal
Pro-B-Type Natriuretic Peptide Provides Early Assessment of
Severity in Cardiogenic Shock Complicating Acute Coronary
Syndrome

J 2017

Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome

TOLPPANEN, H., R.L. MERCEDES, J. LASSUS, M. SADOUNE, E. GAYAT et. al.

Základní údaje

Originální název

Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome

Autoři

TOLPPANEN, H., R.L. MERCEDES, J. LASSUS, M. SADOUNE, E. GAYAT, K. PULKKI, M. ARRIGO, E. KRASTINOVA, A. SIONIS, J. PARISSIS, Jindřich ŠPINAR, J. JANUZZI, V.P. HARJOLA a A. MEBAZAA

Vydání

Critical Care Medicine, Philadelphia, Lippincott Williams & Wilkins, 2017, 0090-3493

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30218 General and internal medicine

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 6.630

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1097/CCM.0000000000002336

UT WoS

000403475400005

Klíčová slova anglicky

amino-terminal pro-B-type natriuretic peptide; biomarkers; cardiogenic shock; prognosis; ST2

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 20. 3. 2018 16:50, Soňa Böhmová

Anotace

V originále

Objectives: Mortality in cardiogenic shock complicating acute coronary syndrome is high, and objective risk stratification is needed for rational use of advanced therapies such as mechanical circulatory support. Traditionally, clinical variables have been used to judge risk in cardiogenic shock. The aim of this study was to assess the added value of serial measurement of soluble ST2 and amino-terminal pro-B-type natriuretic peptide to clinical parameters for risk stratification in cardiogenic shock. Design: CardShock (www.clinicaltrials.gov NCT01374867) is a prospective European multinational study of cardiogenic shock. The main study introduced CardShock risk score, which is calculated from seven clinical variables at baseline, and was associated with short-term mortality. Setting: Nine tertiary care university hospitals. Patients: Patients with cardiogenic shock caused by acute coronary syndrome (n=145). Interventions: In this substudy, plasma samples from the study patients were analyzed at eight time points during the ICU or cardiac care unit stay. Additional prognostic value of the biomarkers was assessed with incremental discrimination improvement. Measurements and Main Results: The combination of soluble ST2 and amino-terminal pro-B-type natriuretic peptide showed excellent discrimination for 30-day mortality (area under the curve, 0.77 at 12 hr up to 0.93 at 5-10 d after cardiogenic shock onset). At 12 hours, patients with both biomarkers elevated (soluble ST2, >= 500 ng/mL and amino-terminal pro-B-type natriuretic peptide, >= 4,500 ng/L) had higher 30-day mortality (79%) compared to those with one or neither biomarkers elevated (31% or 10%, respectively; p < 0.001). Combined measurement of soluble ST2 and amino-terminal pro-B-type natriuretic peptide at 12 hours added value to CardShock risk score, correctly reclassifying 11% of patients. Conclusions: The combination of results for soluble ST2 and amino-terminal pro-B-type natriuretic peptide provides early risk assessment beyond clinical variables in patients with acute coronary syndrome-related cardiogenic shock and may help therapeutic decision making in these patients.

Citovat

TOLPPANEN, H., R.L. MERCEDES, J. LASSUS, M. SADOUNE, E. GAYAT, K. PULKKI, M. ARRIGO, E. KRASTINOVA, A. SIONIS, J. PARISSIS, Jindřich ŠPINAR, J. JANUZZI, V.P. HARJOLA a A. MEBAZAA. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome. Critical Care Medicine. Philadelphia: Lippincott Williams & Wilkins, 2017, roč. 45, č. 7, s. "E666"-"E673", 8 s. ISSN 0090-3493. Dostupné z: https://dx.doi.org/10.1097/CCM.0000000000002336.

@article{1398871,
   author = {Tolppanen, H. and Mercedes, R.L. and Lassus, J. and Sadoune, M. and Gayat, E. and Pulkki, K. and Arrigo, M. and Krastinova, E. and Sionis, A. and Parissis, J. and Špinar, Jindřich and Januzzi, J. and Harjola, V.P. and Mebazaa, A.},
   article_location = {Philadelphia},
   article_number = {7},
   doi = {http://dx.doi.org/10.1097/CCM.0000000000002336},
   keywords = {amino-terminal pro-B-type natriuretic peptide; biomarkers; cardiogenic shock; prognosis; ST2},
   language = {eng},
   issn = {0090-3493},
   journal = {Critical Care Medicine},
   title = {Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome},
   url = {http://dx.doi.org/10.1097/CCM.0000000000002336},
   volume = {45},
   year = {2017}
}

TY  - JOUR
ID  - 1398871
AU  - Tolppanen, H. - Mercedes, R.L. - Lassus, J. - Sadoune, M. - Gayat, E. - Pulkki, K. - Arrigo, M. - Krastinova, E. - Sionis, A. - Parissis, J. - Špinar, Jindřich - Januzzi, J. - Harjola, V.P. - Mebazaa, A.
PY  - 2017
TI  - Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome
JF  - Critical Care Medicine
VL  - 45
IS  - 7
SP  - "E666"-"E673"
EP  - "E666"-"E673"
PB  - Lippincott Williams & Wilkins
SN  - 00903493
KW  - amino-terminal pro-B-type natriuretic peptide
KW  - biomarkers
KW  - cardiogenic shock
KW  - prognosis
KW  - ST2
UR  - http://dx.doi.org/10.1097/CCM.0000000000002336
L2  - http://dx.doi.org/10.1097/CCM.0000000000002336
N2  - Objectives: Mortality in cardiogenic shock complicating acute coronary syndrome is high, and objective risk stratification is needed for rational use of advanced therapies such as mechanical circulatory support. Traditionally, clinical variables have been used to judge risk in cardiogenic shock. The aim of this study was to assess the added value of serial measurement of soluble ST2 and amino-terminal pro-B-type natriuretic peptide to clinical parameters for risk stratification in cardiogenic shock. Design: CardShock (www.clinicaltrials.gov NCT01374867) is a prospective European multinational study of cardiogenic shock. The main study introduced CardShock risk score, which is calculated from seven clinical variables at baseline, and was associated with short-term mortality. Setting: Nine tertiary care university hospitals. Patients: Patients with cardiogenic shock caused by acute coronary syndrome (n=145). Interventions: In this substudy, plasma samples from the study patients were analyzed at eight time points during the ICU or cardiac care unit stay. Additional prognostic value of the biomarkers was assessed with incremental discrimination improvement. Measurements and Main Results: The combination of soluble ST2 and amino-terminal pro-B-type natriuretic peptide showed excellent discrimination for 30-day mortality (area under the curve, 0.77 at 12 hr up to 0.93 at 5-10 d after cardiogenic shock onset). At 12 hours, patients with both biomarkers elevated (soluble ST2, >= 500 ng/mL and amino-terminal pro-B-type natriuretic peptide, >= 4,500 ng/L) had higher 30-day mortality (79%) compared to those with one or neither biomarkers elevated (31% or 10%, respectively; p < 0.001). Combined measurement of soluble ST2 and amino-terminal pro-B-type natriuretic peptide at 12 hours added value to CardShock risk score, correctly reclassifying 11% of patients. Conclusions: The combination of results for soluble ST2 and amino-terminal pro-B-type natriuretic peptide provides early risk assessment beyond clinical variables in patients with acute coronary syndrome-related cardiogenic shock and may help therapeutic decision making in these patients.
ER  -

TOLPPANEN, H., R.L. MERCEDES, J. LASSUS, M. SADOUNE, E. GAYAT, K. PULKKI, M. ARRIGO, E. KRASTINOVA, A. SIONIS, J. PARISSIS, Jindřich ŠPINAR, J. JANUZZI, V.P. HARJOLA a A. MEBAZAA. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome. \textit{Critical Care Medicine}. Philadelphia: Lippincott Williams \&{} Wilkins, 2017, roč.~45, č.~7, s.~''E666''-''E673'', 8 s. ISSN~0090-3493. Dostupné z: https://dx.doi.org/10.1097/CCM.0000000000002336.

Podrobný výpis o publikaci